Enzyme-based Diagnosis of Classical Late Infantile Neuronal Ceroid Lipofuscinosis: Comparison of Tripeptidyl Peptidase I and Pepstatin-insensitive Protease Assays-Reference-Cited by-同舟云学术

Enzyme-based Diagnosis of Classical Late Infantile Neuronal Ceroid Lipofuscinosis: Comparison of Tripeptidyl Peptidase I and Pepstatin-insensitive Protease Assays

Published:2000-07-01 Issue:7 Volume:46 Page:1005-1008
ISSN:0009-9147
Container-title:Clinical Chemistry
language:en
Short-container-title:

Author:

Sohar Istvan¹,Lin Li¹,Lobel Peter¹

Affiliation:

1. Center for Advanced Biotechnology and Medicine, Department of Pharmacology, Robert Wood Johnson Medical School-University of Medicine and Dentistry of New Jersey, 679 Hoes Lane, Piscataway, NJ 08854

Publisher

Oxford University Press (OUP)

Subject

Biochemistry (medical),Clinical Biochemistry

Link

http://academic.oup.com/clinchem/article-pdf/46/7/1005/32721414/clinchem1005.pdf

Reference13 articles.

1. Mutational Analysis of the Defective Protease in Classic Late-Infantile Neuronal Ceroid Lipofuscinosis, a Neurodegenerative Lysosomal Storage Disorder

2. Molecular genetics of palmitoyl-protein thioesterase deficiency in the U.S.

3. Spectrum of Mutations in the Batten Disease Gene, CLN3

4. Compound heterozygous genotype is associated with protracted juvenile neuronal ceroid lipofuscinosis

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A mouse mutant deficient in both neuronal ceroid lipofuscinosis‐associated proteins CLN3 and TPP1;Journal of Inherited Metabolic Disease;2023-04-26

2. Clinical management and diagnosis of CLN2 disease: consensus of the Brazilian experts group;Arquivos de Neuro-Psiquiatria;2023-03

3. Activation of mitochondrial TRAP1 stimulates mitochondria-lysosome crosstalk and correction of lysosomal dysfunction;iScience;2022-09

4. Recent Insight into the Genetic Basis, Clinical Features, and Diagnostic Methods for Neuronal Ceroid Lipofuscinosis;International Journal of Molecular Sciences;2022-05-20

5. Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients;Orphanet Journal of Rare Diseases;2021-04-21